WHO

In an effort to understand the prevalence of thalassaemic syndromes and the existent blood supply system available within each country of the South-East Asia Region, the WHO Regional Office for…

TIF has participated in the 71st session of the WHO Regional Committee for Europe between 13–15 September 2021, which gathered six hundred high-level delegates, including over 30 Health Ministers from…

The U.S. Food and Drug Administration (FDA) and the U.S. Centers for Disease Control and Prevention (CDC)  have both recommended on August 16 that certain immunocompromised people receive a third…

The World Health Organization (WHO) announced yesterday that it has approved a COVID-19 vaccine made by Sinovac Biotech (SVA.O) for emergency use listing, paving the way for a second Chinese shot…

In celebration of the International Thalassaemia Day 2021,  the Thalassaemia International Federation (TIF) proudly presents a High-level Event for the Official Premiere of the Federation’s Global Thalassaemia Review, to take…

We are very proud to inform you that TIF remains in official relations with the World Health Organization (WHO) for 2021-2024 The extension of ΤIF’s official relations with WHO was…

On 16 – 18 November 2007, a joint WHO – TIF meeting was held in Nicosia, Cyprus, entitled: “The Management of Haemoglobin Disorders”. The meeting was convened at the request…